Synlogic Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
/ 
Frequently asked questions
To buy Synlogic Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Synlogic Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Synlogic Inc. is SYBX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Synlogic Inc. has its primary listing on NASDAQ. You can trade Synlogic Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Synlogic Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Synlogic Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Synlogic Inc..